Growth in Enteral Feeding Devices Market is driven by the rising healthcare costs, surge in the number of preterm births, growth in the aging population, rising prevalence of chronic diseases, growing awareness of enteral nutrition, and improvements in healthcare facilities in emerging countries. Furthermore, the rising demand for user-friendly feeding devices and technological advancements are contributing to the growth of this market.
According to the new market research report "Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Diabetes, Hypermetabolism), End User (Hospital, Home Care) - Global Forecast to 2024", published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2024 from USD 2.9 billion in 2019, at a CAGR of 6.7%.
Get Crucial Insights:
Shift From Parenteral to Enteral Nutrition:
Enteral nutrition is more physiological, with fewer complications as compared to parenteral nutrition. The major advantage of enteral nutrition is the maintenance of the GI mucosal barrier, stimulating intestinal blood flow. Enteral administration also helps in maintaining small intestine mass and pancreatic functions, improves healing & recovery, reduces muscle catabolism, and lowers the risk of infection and contamination. According to an article published in the German Medical Science journal, major septic complications affect only 3% of patients on enteral nutrition as compared to over 20% of those on parenteral nutrition.
Technological advancements have also led to the development of compact and portable enteral feeding pumps, which are constructed using materials that prevent cracking in high-stress applications. Advanced features in pumps include appropriate programming options, programmed flushing intervals, multiple language options, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation. Enhancements in pump designs (according to the requirements of healthcare providers and patients) and growth in the home healthcare market (enabling enteral feeding of nutrients to patients at home) are expected to propel the growth of the enteral feeding pumps market.
Feeding tubes are also available in various lengths, diameters, and material types, facilitating the convenient administration of liquid products. In enteral administration, nutrients can also be delivered in various formats such as tablets or capsules (instead of sterile liquids or rehydratable powders).
Furthermore, the cost of enteral nutrition is lower than parenteral nutrition. The average cost of enteral nutrition per patient per day is about 40% of that of parenteral nutrition. These benefits have led to a significant increase in the adoption of enteral feeding in various treatment regimes.
Oncology formed the largest application segment of enteral feeding devices in 2018
Based on application, the market is segmented into oncology, gastrointestinal disorders, neurological disorders, diabetes, hypermetabolism, and other applications. In 2018, oncology accounted for the largest share of the market due to the increasing prevalence of various types of cancers and the reliance of cancer patients on external nutrition.
North America to dominate the enteral feeding devices market during the forecast period
In 2018, North America dominated the global market, followed by Europe. The large share of North America can be attributed to the high adoption of enteral feeding devices among the aging population, increasing prevalence of chronic diseases, the presence of many large hospitals, a shift from parenteral to enteral feeding, and the development of innovative products. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
Please share your specific interest to serve you better.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=183623035
Prominent players in the enteral feeding devices market include Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), and CONMED Corporation (CONMED) (US).